Orthocell has entered an MOU to secure exclusive distribution rights for Marine Biomedical's innovative bone substitute PearlBone, and lift its stake in the company to 12 per cent.
53 min ago
Orthocell to up stake in ‘groundbreaking’ pearl bone substitute
53 min ago
